GoodRx Holdings's biggest risks in the FY2024 10-K
- The business remains heavily exposed to prescription transactions, negotiated pricing, PBMs and national pharmacy chains.
- Growth depends on consumer adoption, digital distribution, and expanding telehealth and pharma manufacturer offerings.
- Data privacy, messaging, technology, and regulatory compliance create additional operating and legal exposure.
The risks most specific to GoodRx Holdings
- Risks Related to Our Business
We rely significantly on our prescription transactions offering and may not be successful in expanding our offerings within our markets, particularly the U.S. prescriptions market, or to other segments of the healthcare industry
Most revenue comes from prescription transactions, leaving GoodRx exposed if it cannot expand beyond prescriptions or grow other healthcare offerings.
- Risks Related to Our Business
Our business is subject to changes in medication pricing and is significantly impacted by pricing structures negotiated by industry participants
Changes in medication prices and industry-negotiated pricing structures could reduce the discounts GoodRx can display and the fees it earns.
- Risks Related to Our Business
We generally do not control the categories and types of prescriptions for which we can offer savings or discounted prices
PBMs, pharmacies and pharma manufacturers largely control which medications and brands receive discounts on GoodRx.
- Risks Related to Our Business
Consolidation of PBMs or the loss of a PBM could negatively impact the discounts and prices that we present through our platform and may result in less competitive discounts and prices on our platform
Consolidation or loss of a PBM could reduce the competitiveness of discounts available through GoodRx codes at more than 70,000 pharmacies.
- Risks Related to Our Business
The impact of the changing retail pharmacy landscape is currently unknown, but may adversely affect our business, financial condition, and results of operations
Pharmacy closures or less competitive cash-network contracts with GoodRx-related PBMs could reduce available discounts and harm revenue.
- Risks Related to Our Business
Our telehealth offering is dependent on our ability to maintain our relationship with our telehealth provider network, including our affiliated professional entities, and the ability of such entities to recruit qualified telehealth providers
GoodRx’s telehealth offering depends on affiliated professional entities maintaining provider relationships and recruiting enough qualified telehealth providers.
- Risks Related to Our Business
We may be unable to successfully respond to changes in the market for prescription pricing, and may fail to maintain and expand the use of GoodRx codes through our apps and websites
GoodRx must keep shifting prescription-discount usage toward its apps and websites as consumer preferences move from offline channels to digital ones.
- Risks Related to Our Business
A variety of federal and state laws, regulations and regulatory interpretations govern the collection, use, retention, sharing and security of consumer data, particularly in the context of online advertising, which we rely upon to attract new consumers
Changing federal and state privacy, data-protection, advertising and consumer-protection rules could restrict GoodRx’s use of consumer data to acquire users.
- Risks Related to Our Business
Though we have wound down vitaCare Prescription Services, Inc.’s ("vitaCare") principal operations, vitaCare's past activities could be subject to regulation and enforcement by the federal government and the states in which vitaCare conducted its business, including state licensing of pharmacies and pharmacists
Although vitaCare’s principal operations are wound down, its past pharmacy activities could still trigger federal or state licensing enforcement.
All 68 risk factors
Headings as the filing states them, in filing order.
Risks Related to Our Limited Operating History and Recent Growth Rates
- 01Our limited operating history and our evolving business make it difficult to evaluate our future prospects and the risks and challenges we may encounter
- 02Our recent growth rates may not be sustainable or indicative of future growth
- 03Our results of operations vary and may fluctuate significantly from period-to-period
- 04We may be unable to manage our future growth effectively, which could make it difficult to execute our business strategy
Risks Related to Our Business
- 05We may be unsuccessful in achieving broad market education and changing consumer purchasing habits
- 06We may be unable to continue to attract, acquire and retain consumers, or may fail to do so in a cost-effective manner
- 07We rely significantly on our prescription transactions offering and may not be successful in expanding our offerings within our markets, particularly the U.S. prescriptions market, or to other segments of the healthcare industry
- 08Our business is subject to changes in medication pricing and is significantly impacted by pricing structures negotiated by industry participants
- 09We generally do not control the categories and types of prescriptions for which we can offer savings or discounted prices
- 10We rely on a limited number of industry participants
- 11Consolidation of PBMs or the loss of a PBM could negatively impact the discounts and prices that we present through our platform and may result in less competitive discounts and prices on our platform
- 12The impact of the changing retail pharmacy landscape is currently unknown, but may adversely affect our business, financial condition, and results of operations
- 13We operate in a very competitive industry and we may fail to effectively differentiate our offerings and services from those of our competitors, which could impair our ability to attract and acquire new consumers and retain existing consumers
- 14Our estimated addressable market is subject to inherent challenges and uncertainties. If we overestimate the size of our addressable market or the various markets in which we operate, our future growth opportunities may be limited
- 15We calculate certain operational metrics using internal systems and tools and do not independently verify such metrics. Certain metrics are subject to inherent challenges in measurement, and real or perceived inaccuracies in such metrics may harm our reputation and negatively affect our business
- 16Our telehealth offering is dependent on our ability to maintain our relationship with our telehealth provider network, including our affiliated professional entities, and the ability of such entities to recruit qualified telehealth providers
- 17Negative media coverage could adversely affect our business
- 18We may be unable to successfully respond to changes in the market for prescription pricing, and may fail to maintain and expand the use of GoodRx codes through our apps and websites
- 19Our compliance with Section 404 requires that we incur substantial costs and expend significant management efforts
- 20Use of social media, emails and text messages may adversely impact our reputation, subject us to fines or other penalties or be an ineffective source to market our offerings
- 21We rely on information technology to operate our business and maintain competitiveness, and must adapt to technological developments or industry trends
- 22We depend on the use of information technologies and systems. As our operations grow, we must continuously improve and upgrade our systems and infrastructure while maintaining or improving the reliability and integrity of our infrastructure
- 23We depend on our information technology systems, and those of our third-party vendors, contractors and consultants, and any failure or significant disruptions of these systems, security breaches or loss of data could materially adversely affect our business, financial condition and results of operations
- 24We are subject to general business regulations and laws specifically governing the internet and e-commerce
- 25Our business relies on email, mail and other messaging channels and any technical, legal or other restrictions on the sending of such correspondence or a decrease in consumer willingness to receive such correspondence could adversely affect our business
- 26We face the risk of litigation resulting from unauthorized text messages sent in violation of the Telephone Consumer Protection Act
- 27A variety of federal and state laws, regulations and regulatory interpretations govern the collection, use, retention, sharing and security of consumer data, particularly in the context of online advertising, which we rely upon to attract new consumers
- 28Though we have wound down vitaCare Prescription Services, Inc.’s ("vitaCare") principal operations, vitaCare's past activities could be subject to regulation and enforcement by the federal government and the states in which vitaCare conducted its business, including state licensing of pharmacies and pharmacists
- 29Our ability to utilize our net operating loss carryforwards and certain other tax attributes may be limited
- 30We rely on the performance of members of management and highly skilled personnel, and if we are unable to attract, develop, motivate and retain well-qualified employees, our business could be harmed
- 31Any pandemic, endemic or other infectious disease may adversely affect our business, results of operations, and financial condition by changing the way our consumers access healthcare and utilize our platform, or by causing us to modify our business practices
- 32General economic factors, natural disasters or other unexpected events may adversely affect our business, financial performance and results of operations
- 33Restrictions in our debt arrangements could adversely affect our operating flexibility, and failure to comply with any of these restrictions could result in acceleration of our debt
- 34Our business depends on network and mobile infrastructure and our ability to maintain and scale our technology
- 35A key element of our strategy is to generate a significant number of visitors to, and their use of, our apps and websites
- 36Some of our vendor agreements may be unilaterally terminated by the licensor for convenience, including with respect to services provided by Google, and if such agreements are terminated, we may not be able to enter into similar relationships in the future on reasonable terms or at all
- 37We rely on third-party platforms such as the Apple App Store and Google Play App Store, to distribute our platform and offerings
- 38We rely on software-as-a-service (“SaaS”) technologies from third parties
- 39We depend on our relationships with third parties and would be adversely impacted by system failures or other disruptions in the operations of these parties
- 40We are subject to a series of risks related to climate change
- 41To the extent we are subject to such activism, it may require us to incur costs or otherwise adversely impact our business
Risks Related to Intellectual Property
- 42We may be unable to establish, maintain, protect and enforce our intellectual property and proprietary rights or prevent third parties from making unauthorized use of our technology
- 43Third parties have asserted, and may in the future assert, that we have infringed, misappropriated or otherwise violated their intellectual property rights
- 44We may be unable to continue the use of our trademarks, trade names or domain names, or prevent third parties from acquiring and using trademarks, trade names and domain names that infringe on, are similar to, or otherwise decrease the value of our brands, trademarks or service marks
- 45If we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed
- 46Issued patents covering our offerings could be found invalid or unenforceable if challenged
- 47We utilize open source software, which may pose particular risks to our proprietary software and solutions
- 48If we fail to comply with our obligations under license or technology agreements with third parties, we may be required to pay damages and we could lose license rights that are critical to our business
Risks Related to the Healthcare Industry
- 49Our telehealth offering offered to consumers is subject to various state laws and regulations governing the provision of telehealth services
- 50Our telehealth offering and relationships with our affiliated physician-owned professional entities may implicate laws governing the practice of medicine and fee-splitting
- 51New and changing laws, regulations, executive orders and other governmental actions, particularly from the new presidential administration, may also create uncertainty about how laws and regulations will be interpreted and applied
- 52Congress has and is likely to continue to scrutinize key participants in the healthcare industry, including PBMs. A number of bills have been introduced in Congress that would further regulate PBMs and impose additional requirements
Risks Related to Our Organizational Structure, including Agreements and Relationships with Significant Stockholders
- 53Our capital structure may adversely affect the trading market for our Class A common stock
- 54The concentration of ownership could deprive investors of an opportunity to receive a premium for their shares of Class A common stock as part of a sale of our company and ultimately might affect the market price of our Class A common stock
- 55Substantial future sales by the parties to our stockholders agreement or other holders of our common stock, or the perception that such sales may occur, could depress the price of our Class A common stock
- 56Delaware law and provisions in our amended and restated certificate of incorporation and amended and restated bylaws could make a merger, tender offer or proxy contest more difficult, limit attempts by our stockholders to replace or remove our current management and limit the market price of our Class A common stock
- 57Our amended and restated certificate of incorporation provides that the doctrine of “corporate opportunity” does not apply with respect to certain parties to our stockholders agreement and any director or stockholder who is not employed by us or our subsidiaries
- 58We do not intend to pay dividends for the foreseeable future
- 59We are a holding company and depend on our subsidiaries for cash to fund operations and expenses, including future dividend payments, if any
General Risk Factors
- 60We may be unable to accurately forecast revenue and appropriately plan our expenses in the future
- 61We may experience fluctuations in our tax obligations and effective income tax rate, which could materially and adversely affect our results of operations
- 62We may need additional capital in the future, which may not be available to us on favorable terms, or at all, and may dilute your ownership of our Class A common stock
- 63Changes in U.S. patent law could diminish the value of patents in general, thereby impairing our ability to protect our platform or features of our platform and offerings
- 64We may not be able to enforce our intellectual property rights throughout the world
- 65We may be subject to claims that our employees, consultants, or advisors have wrongfully used or disclosed alleged trade secrets of their current or former employers or claims asserting ownership of what we regard as our own intellectual property
- 66If we cannot license rights to use technologies on reasonable terms, we may not be able to commercialize new solutions or services in the future
- 67Our stock price may be volatile or may decline regardless of our operating performance, resulting in substantial losses for investors
- 68The stock market has recently experienced extreme price and volume fluctuations. The market prices of securities of companies have experienced fluctuations that often have been unrelated or disproportionate to their results of operations
Other GoodRx Holdings 10-Ks
- FY2025 10-K risk factors73 risks11 new6 dropped13 reworded
New risks emphasize dependence on pharmacy chains, consumer trust, AI, restructuring, strategic transactions, and concentrated control.
Filed Feb 26, 2026
About this page
The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.